Poland· PL-100532365
Waskyra
A medicinal product containing etuvetidigenum autotemcelum 2–10 × 10^6 komórek/ml, registered in Poland by Fondazione Telethon ETS.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Etuvetidigenum autotemcelum 2–10 × 10^6 komórek/ml
- Manufacturer
- Fondazione Telethon ETS
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Etuvetidigenum autotemcelum 2–10 × 10^6 komórek/ml in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesWASKYRAOrphan Therapies LLC
- BelgiumWaskyra 2 10*6 cells/ml - 10 10*6 cells/mlFondazione Telethon ETS
- CzechiaWASKYRAFondazione Telethon ETS, Řím
- FinlandWaskyraFondazione Telethon Ets
- NetherlandsWaskyra 2-10 x 10^6 cellen/ml dispersie voor infusieFondazione Telethon
- SwedenWaskyra 2 - 10 miljoner celler/ml Infusionsvätska, dispersionFondazione Telethon ETS
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Waskyra
- Liechtenstein · Waskyra
- Norway · Waskyra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/59cdfcd7-3843-483c-9bc5-0175c03d379a GET /v1/drugs/59cdfcd7-3843-483c-9bc5-0175c03d379a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Dyspersja do infuzji",
"source": "urpl",
"strength": "2–10 × 10^6 komórek/ml",
"packaging": "Rpz ¦ EU/1/25/1996/001 ¦ 165639\n1 worek o pojemności 10–20 ml",
"substance": "Etuvetidigenum autotemcelum 2–10 × 10^6 komórek/ml",
"common_name": null,
"pl_product_id": "100532365",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about etuvetidigenum autotemcelum 2–10 × 10^6 komórek/ml.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.